In vitro anti-HBV assay
Drug stock solutions were prepared in DMSO and stored at -70 °C. Upon dilution into culture medium, the final DMSO concentration was <1 % DMSO (v/v), a concentration without an effect on cell replication. Cell culture and other procedures were the same as those reported previously [25] . A HepG2-derived human hepatablastoma cell line, 2.2.15, was used in this study, which was transfected with cloned HBV DNA to produce HBV particles. All stock cultures were grown in T-25 flasks containing DMEM supplemented with 10% (v/v) fetal bovine serum, 0.03% (v/v) L-glutamine, 100 μg/mL penicillin, 100 μg/mL streptomycin, and 380 μg/mL G418 at 37 °C in a humidified atmosphere containing 5% CO 2 . After the HepG2 2.2.15 cell suspensions seeded in 24-well microtiter plates were cultured for 48 h, they were incubated at 37 °C for 9 days in the presence of various concentrations of drugs (200, 100, 50, and 25 μg/mL, respectively) from DMSO-diluted stock, and the medium was refreshed every 3 days. Then the culture supernatants were harvested to detect HBsAg and HBeAg secretions using diagnostic ELISA kits (Shanghai SIIC KEHUA Biotech Co., Ltd.) as described, in triplicate, and the SEM (standard error of the mean) of inhibition values varied no more than 5%. Cell damage was assessed using the MTT assay. Lamivudine (3TC) was used as the positive control, which was obtained from GSK and its purity was more than 99%.
In vitro anti-HIV assay
The anti-HIV inhibitory assay was performed at Panacos Pharmaceuticals according to the following procedure [24] . The H9 T cell line was maintained in continuous culture with complete medium (RPMI 1640 and 10% fetal calf serum) at 5% CO 2 and 37 °C, and was used in experiments only when in the log phase of growth. The cells were incubated with HIV-1 (IIIB isolate, TCID 50 10 4 IU/mL, at a multiplicity of infection of 0.1-0.01 IU/cell) for 1 h at 5% CO 2 and 37 °C. The cells were then washed thoroughly to remove unabsorbed virions and resuspended at 4 × 105 cells/mL. Aliquots (1 mL) were placed in 24-well culture plates containing an equal volume of test compound (diluted in the culture medium). After a 4-day incubation at 37 °C, the cell density of uninfected cultures was determined by counting cells in a Coulter counter to assess toxicity of the test compound. A p24-antigen ELISA assay was used to determine the level of virus released in the medium of the HIV-infected cultures. The p24-antigen assay uses an HIV-1 anti-p24 specific monoclonal antibody as the capture antibody coated on 96-well plates. Following a sample incubation period, rabbit serum containing antibodies for HIV-1 p24 was used to tag any p24 "captured" onto the microtiter well surface. Peroxidase-conjugated goat anti-rabbit serum was then used to tag HIV-1 p24 specific rabbit antibodies that have complexed with captured p24. The presence of p24 in test samples was then revealed by the addition of the substrate. The cutoff for the p24 ELISA assay was 12.5 pg/mL; p24 in the culture medium was quantitated against a standard curve containing known amounts of p24. The effective (EC 50 ) and inhibitory (IC 50 ) concentrations (for anti-HIV activity and cytotoxicity, respectively) were determined. Azidothymidine (AZT) was used as the positive control, which was obtained from Sigma-Aldrich and its purity was more than 98%. 
